These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 32891200)

  • 1. Clinical endpoints are necessary in the interim analysis of REGENERATE - Authors' reply.
    Ratziu V; Younossi ZM; Campagna JA; MacConell L; Sanyal AJ
    Lancet; 2020 Sep; 396(10252):663-664. PubMed ID: 32891200
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical endpoints are necessary in the interim analysis of REGENERATE.
    Malnick S; Somin M
    Lancet; 2020 Sep; 396(10252):663. PubMed ID: 32891201
    [No Abstract]   [Full Text] [Related]  

  • 3. Ajmaline-induced Epsilon wave: as a potential interim risk factor between the spontaneous and drug-induced type 1 Brugada electrogram?- Authors' reply.
    Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Europace; 2018 Jul; 20(7):1226. PubMed ID: 29893820
    [No Abstract]   [Full Text] [Related]  

  • 4. Authors' reply to comment What should be the endpoints of a symptomatic drug and its control?
    Mesa R; Harrison C
    Lancet Haematol; 2017 Nov; 4(11):e508-e509. PubMed ID: 29100557
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.
    Meinel AB; Meinel MP
    Appl Opt; 1985 Apr; 24(7):944. PubMed ID: 20436652
    [No Abstract]   [Full Text] [Related]  

  • 6. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.
    Choolani M; Biswas A
    Singapore Med J; 2013 Apr; 54(4):238. PubMed ID: 23624457
    [No Abstract]   [Full Text] [Related]  

  • 8. Interim decision-making strategies in adaptive designs for population selection using time-to-event endpoints.
    Uozumi R; Hamada C
    J Biopharm Stat; 2017; 27(1):84-100. PubMed ID: 26881477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Authors' Reply to "Both Macro and Micro Filarial Treatment May Be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection".
    Takaya S; Kutsuna S; Kato Y; Ohmagari N
    Intern Med; 2019 Aug; 58(16):2425. PubMed ID: 30996199
    [No Abstract]   [Full Text] [Related]  

  • 10. Is discussion of dengue vaccination for the 2016 Olympics necessary?: Authors' reply.
    Halstead SB; Aguiar M
    Lancet; 2016 Oct; 388(10054):1881-1882. PubMed ID: 27751396
    [No Abstract]   [Full Text] [Related]  

  • 11. Authors' reply: megablocks are nice but not really necessary.
    Varma M; Dormer J
    J Clin Pathol; 2024 Jun; ():. PubMed ID: 38876774
    [No Abstract]   [Full Text] [Related]  

  • 12. Decision on performing interim analysis for comparative clinical trials.
    Pak K; Jacobus S; Uno H
    Contemp Clin Trials Commun; 2017 Sep; 7():224-230. PubMed ID: 29696190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Authors' Reply.
    Li MM; Datto M; Duncavage EJ; Kulkarni S; Lindeman NI; Roy S; Tsimberidou AM; Vnencak-Jones CL; Wolff DJ; Younes A; Nikiforova MN
    J Mol Diagn; 2018 Jan; 20(1):125-126. PubMed ID: 29249244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: IDASPHERE phase I trial for chemoembolisation for HCC - authors' reply: a necessary step for treatment optimisation and standardisation.
    Boulin M; Bedenne L; Guiu B
    Aliment Pharmacol Ther; 2014 Jul; 40(2):210-1. PubMed ID: 24946061
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.
    Allen MD; Doherty TJ; Rice CL; Kimpinski K
    J Appl Physiol (1985); 2016 Jul; 121(1):361. PubMed ID: 27451279
    [No Abstract]   [Full Text] [Related]  

  • 16. Authors' reply-A sensitivity analysis of the RAPIDO clinical trial.
    Dijkstra EA; Zwart WH; Putter H; Marijnen CAM; Nilsson PJ; van de Velde CJH; van Etten B; Hospers GAP; Glimelius B
    Ann Oncol; 2023 Apr; 34(4):446-447. PubMed ID: 36581138
    [No Abstract]   [Full Text] [Related]  

  • 17. Information time scales for interim analyses of randomized clinical trials.
    Freidlin B; Othus M; Korn EL
    Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim endodontic therapy for alveolar socket bone regeneration of infected hopeless teeth prior to implant therapy.
    Rass MA
    J Oral Implantol; 2010; 36(1):37-59. PubMed ID: 20218869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".
    Ettinger S; Stanak M; Szymański P; Wild C; Tandara Haček R; Erčević D; Grenković R; Goetz G; Huić M
    Med Devices (Auckl); 2019; 12():129-131. PubMed ID: 30962728
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim monitoring of clinical trials based on long-term binary endpoints.
    Marschner IC; Becker SL
    Stat Med; 2001 Jan; 20(2):177-92. PubMed ID: 11169596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.